Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Hum Genet ; 13(1): 96-101, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15367919

RESUMO

It has been suggested that genes other than CFTR could modulate the severity of lung disease in cystic fibrosis (CF). Neutrophil Fcgamma receptor II (FcgammaRII) is involved in host defense against microorganisms and in inflammatory response. We evaluated the association between genetic variability of this gene and both airway infection with Pseudomonas aeruginosa and severity of lung disease in patients with CF. We studied 167 Italian unrelated patients with CF and 50 control subjects. The distribution of FcgammaRIIA genotypes in CF patients was compared with that in control subjects and the different genotypes were related with the presence or absence of P. aeruginosa infection and markers of disease severity in CF patients. The distribution of FcgammaRIIA genotypes was not significantly different between CF patients and controls. We observed that in CF patients with the same CFTR genotype (DeltaF508/DeltaF508), those carrying the R allele of FcgammaRIIA had an increased risk of acquiring chronic P. aeruginosa infection (P=0.042, R.R.: 4.38; 95% CI: 1.17/22.4). Moreover, the frequency of R/R genotype in patients with chronic P. aeruginosa infection seems to be higher than that of control subjects and patients without chronic infection. The observation that CF patients carrying the R allele of FcgammaRIIA are at higher risk of acquiring chronic P. aeruginosa infection suggests that the FcgammaRII loci genetic variation is contributing to this infection susceptibility.


Assuntos
Fibrose Cística/genética , Fibrose Cística/microbiologia , Genótipo , Infecções por Pseudomonas/genética , Receptores de IgG/genética , Adolescente , Adulto , Alelos , Estudos de Casos e Controles , Criança , Fibrose Cística/imunologia , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Suscetibilidade a Doenças , Feminino , Variação Genética , Humanos , Masculino , Pessoa de Meia-Idade , Neutrófilos/metabolismo , Infecções por Pseudomonas/imunologia , Pseudomonas aeruginosa/genética , Pseudomonas aeruginosa/imunologia
2.
Hepatology ; 36(6): 1374-82, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12447862

RESUMO

Incidence of liver disease (LD) associated with cystic fibrosis (CF) and its clinical characterization still is unsettled. We have assessed prospectively the incidence and risk factors of this complication, and its impact on the clinical course of CF. Between 1980 and 1990, we enrolled 177 CF patients without LD in a systematic clinical, laboratory, ultrasonography screening program of at least a 10-year duration. During a 14-year median follow-up (2,432 patient-years), 48 patients developed LD, with cirrhosis already present in 5. Incidence rate (number of cases per 100 patient-years) was 1.8% (95% confidence interval: 1.3-2.4), with sharp decline after the age of 10 years and higher risk in patients with a history of meconium ileus (incidence rate ratio, 5.5; 2.7-11), male sex (2.5; 1.3-4.9), or severe mutations (2.4; 1.2-4.8) at multivariate analysis. Incidence of cirrhosis was 4.5% (2.3-7.8) during a median period of 5 years from diagnosis of liver disease. Among the 17 cirrhotic patients, 13 developed portal hypertension, 4 developed esophageal varices, 1 developed liver decompensation requiring liver transplantation. Development of LD did not condition different mortality (death rate ratio, 0.4; 0.1-1.5) or higher incidence of other clinically relevant outcomes. In conclusion, LD is a relatively frequent and early complication of CF, whose detection should be focused at the first life decade in patients with history of meconium ileus, male sex, or severe genotype. Although LD does not condition a different clinical course of CF, in some patients it may progress rapidly and require liver transplantation.


Assuntos
Fibrose Cística/mortalidade , Hepatopatias/mortalidade , Adolescente , Adulto , Criança , Pré-Escolar , Fibrose Cística/genética , Feminino , Predisposição Genética para Doença/epidemiologia , Genótipo , Humanos , Incidência , Lactente , Hepatopatias/genética , Masculino , Modelos de Riscos Proporcionais , Estudos Prospectivos , Fatores de Risco
3.
J Mol Med (Berl) ; 80(8): 499-506, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12185450

RESUMO

The effect of interferon (IFN) gamma on cationic liposome-mediated gene transfer into primary respiratory epithelial cells was investigated. Treatment of primary respiratory epithelial cells with IFN-gamma resulted in a dose-dependent increase in the intermediate filament cytokeratin 13 and a decrease in cellular proliferation, indicating that respiratory cells underwent squamous differentiation. IFN-gamma pretreatment resulted in a dramatic inhibition of transfection efficiency mediated by a cationic liposome (DOTAP). Incubation of squamous nasal cells with DOTAP/DNA complexes for various periods at 4 degrees C and evaluation of luciferase levels suggested that IFN-gamma pretreatment inhibits complex binding to the cells. In primary nasal and bronchial cells cytofluorimetric analysis demonstrated that IFN-gamma reduces binding of FITC-labeled complexes. The data indicate that differentiation of respiratory epithelial cells to a squamous phenotype, which may occur in chronic respiratory diseases such as cystic fibrosis, induces a refractory condition to gene transfer by nonviral cationic liposomes.


Assuntos
Células Epiteliais/efeitos dos fármacos , Técnicas de Transferência de Genes , Vetores Genéticos/efeitos dos fármacos , Interferon gama/farmacologia , Lipossomos , Resinas de Troca de Cátion , Linhagem Celular Transformada , Células Cultivadas , Citocinas/genética , Células Epiteliais/fisiologia , Humanos , Interferon gama/metabolismo , Luciferases/metabolismo , Sistema Respiratório/citologia , Transfecção
4.
Chest ; 121(2): 635-6, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11834681

RESUMO

We report what we believe to be the first case of video-assisted sleeve lobectomy in an adolescent girl who had experienced recurrent episodes of lobar pneumonia and received a diagnosis of low-grade mucoepidermoid carcinoma of the left lower lobar bronchus.


Assuntos
Neoplasias Brônquicas/cirurgia , Carcinoma Mucoepidermoide/cirurgia , Pneumonectomia/métodos , Cirurgia Torácica Vídeoassistida/métodos , Adolescente , Feminino , Humanos , Recidiva Local de Neoplasia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...